167 related articles for article (PubMed ID: 1711433)
21. Purification of multiple heat shock proteins from a single tumor sample.
Ménoret A; Bell G
J Immunol Methods; 2000 Apr; 237(1-2):119-30. PubMed ID: 10725457
[TBL] [Abstract][Full Text] [Related]
22. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines.
Li Z
Semin Immunol; 1997 Oct; 9(5):315-22. PubMed ID: 9327526
[TBL] [Abstract][Full Text] [Related]
23. A mouse tumor-specific transplantation antigen is a heat shock-related protein.
Ullrich SJ; Robinson EA; Law LW; Willingham M; Appella E
Proc Natl Acad Sci U S A; 1986 May; 83(10):3121-5. PubMed ID: 3458168
[TBL] [Abstract][Full Text] [Related]
24. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
Fritze D; Kern DH; Waldman SR; Pilch YH
Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
[TBL] [Abstract][Full Text] [Related]
25. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
[TBL] [Abstract][Full Text] [Related]
26. [Dendritic cells and immune function in cancer].
Chaux P
Pathol Biol (Paris); 1995 Dec; 43(10):897-903. PubMed ID: 8786896
[TBL] [Abstract][Full Text] [Related]
27. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
28. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
29. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
30. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1.
Navaratnam M; Deshpande MS; Hariharan MJ; Zatechka DS; Srikumaran S
Vaccine; 2001 Jan; 19(11-12):1425-34. PubMed ID: 11163665
[TBL] [Abstract][Full Text] [Related]
31. Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens.
Appleman LJ; Uyeki J; Frey AB
Int J Cancer; 1995 Jun; 61(6):887-94. PubMed ID: 7540599
[TBL] [Abstract][Full Text] [Related]
32. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96.
Breloer M; Marti T; Fleischer B; von Bonin A
Eur J Immunol; 1998 Mar; 28(3):1016-21. PubMed ID: 9541597
[TBL] [Abstract][Full Text] [Related]
33. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
Graner MW; Romanoski A; Katsanis E
Int J Hyperthermia; 2013 Aug; 29(5):380-9. PubMed ID: 23725202
[TBL] [Abstract][Full Text] [Related]
34. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
35. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Calderwood SK; Theriault JR; Gong J
Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.
Ding LN; Yoshida T; Isobe K; Rahman SM; Nagase F; Yokochi T; Kawashima K; Nakashima I
Jpn J Cancer Res; 1991 Jul; 82(7):841-7. PubMed ID: 1679057
[TBL] [Abstract][Full Text] [Related]
37. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
Tamura Y; Peng P; Liu K; Daou M; Srivastava PK
Science; 1997 Oct; 278(5335):117-20. PubMed ID: 9311915
[TBL] [Abstract][Full Text] [Related]
39. The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.
Lu H; Knutson KL; Gad E; Disis ML
Cancer Res; 2006 Oct; 66(19):9754-61. PubMed ID: 17018635
[TBL] [Abstract][Full Text] [Related]
40. Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins.
Binder RJ; Kelly JB; Vatner RE; Srivastava PK
J Immunol; 2007 Dec; 179(11):7254-61. PubMed ID: 18025167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
